Highlights
ASX: PAR       PARADIGM BIOPHARMACEUTICALS LIMITED..
Last Price Today's Change   Day's Range   Trading Volume
3.13   -0.25 (7.40%)  2.99 - 3.58  2,614,383

Overview

 
Avg Volume (4 weeks):1,000,785
4 Weeks Range:2.96 - 4.12
4 Weeks Price Volatility (%):
14.66%
52 Weeks Range:0.92 - 4.12
52 Weeks Price Volatility (%):
69.06%
Average Price Target:-

Headlines



No recent Headlines for this stock.


Business Background

Paradigm Biopharmaceuticals Limited is a biopharmaceutical company focused on repurposing the drug pentosan polysulfate sodium (PPS) for the treatment of inflammation. The Company is engaged in researching and developing therapeutic products for human use. The Company is a drug repurposing company, which seeks to find new uses for old drugs. The Company has commenced the open labelled Phase II clinical trial, investigating the role of the drug PPS in treating traumatic Bone Marrow Lesions. The Company's Rhinosul has properties consisting of both histamine stabilizing and anti-inflammatory properties. The Company focuses on repurposing PPS under ZILOSUL name, as a treatment for bone marrow edema (BME) lesions following traumatic injury.

  Be the first to like this.
 


 

562  619  626  2491 

ActiveGainersLosers
Top 10 Active Counters
 NameLastChange 
 CLZ 0.0030.00 
 IMU 0.031-0.002 
 TLS 3.77+0.06 
 NWE 0.0040.00 
 S32 2.79+0.08 
 BLK 0.0120.00 
 PWN 0.008-0.002 
 NEC 1.820.00 
 LEG 0.085+0.01 
 NHL 0.0540.00 
Partners & Brokers